PubMed

Regulation of plasma LDL: the apoB paradigm.

Sniderman AD, De Graaf J, Couture P, Williams K, Kiss RS, Watts GF.

Clin Sci (Lond). 2009 Nov 23;118(5):333-9.PMID: 19922416 [PubMed - in process]Related articles

Ethnic Variation in Fat and Lean Body Mass and the Association with Insulin Resistance.

Lear SA, Kohli S, Bondy GP, Tchernof A, Sniderman AD.

J Clin Endocrinol Metab. 2009 Oct 9. [Epub ahead of print]PMID: 19820012 [PubMed - as supplied by publisher]Related articles

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Sniderman AD.

Lancet. 2009 Jul 4;374(9683):25; author reply 26-7. No abstract available. PMID: 19577690 [PubMed - indexed for MEDLINE]Related articles

Why guideline-making requires reform.

Sniderman AD, Furberg CD.

JAMA. 2009 Jan 28;301(4):429-31. No abstract available. PMID: 19176446 [PubMed - indexed for MEDLINE]Related articles

Diabetes, abdominal adiposity, and atherogenic dyslipoproteinemia in women compared with men.

Williams K, Tchernof A, Hunt KJ, Wagenknecht LE, Haffner SM, Sniderman AD.

Diabetes. 2008 Dec;57(12):3289-96. Epub 2008 Sep 22.PMID: 18809621 [PubMed - indexed for MEDLINE]Related articlesFree article

We must prevent disease, not predict events.

Sniderman AD.

J Am Coll Cardiol. 2008 Jul 22;52(4):300-1. No abstract available. PMID: 18634986 [PubMed - indexed for MEDLINE]Related articles

The editor's roundtable: expanded versus standard lipid panels in assessing and managing cardiovascular risk.

Sulkes D, Brown BG, Krauss RM, Segrest JP, Sniderman AD, Roberts WC.

Am J Cardiol. 2008 Mar 15;101(6):828-42. Review. No abstract available. PMID: 18328849 [PubMed - indexed for MEDLINE]Related articles

Age as a modifiable risk factor for cardiovascular disease.

Sniderman AD, Furberg CD.

Lancet. 2008 May 3;371(9623):1547-9. Epub 2008 Mar 5. Review. No abstract available. PMID: 18321568 [PubMed - indexed for MEDLINE]Related articles

The strengths and limitations of the apoB/apoA-I ratio to predict the risk of vascular disease: a Hegelian analysis.

Sniderman AD, Kiss RS.

Curr Atheroscler Rep. 2007 Oct;9(4):261-5. Review.PMID: 18173952 [PubMed - indexed for MEDLINE]Related articles

Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome.

Sniderman AD, Faraj M.

Curr Opin Lipidol. 2007 Dec;18(6):633-7. Review.PMID: 17993808 [PubMed - indexed for MEDLINE]Related articles

Low-density lipoprotein lowering in type 2 diabetes mellitus: how to know how low to go.

Sniderman AD.

Curr Opin Endocrinol Diabetes Obes. 2007 Apr;14(2):116-23. Review.PMID: 17940429 [PubMed - indexed for MEDLINE]Related articles

The apoB/apoA-I ratio and insulin resistance: sorting out the metabolic syndrome.

Sniderman AD.

Eur Heart J. 2007 Nov;28(21):2563-4. Epub 2007 Sep 28. No abstract available. PMID: 17905791 [PubMed - indexed for MEDLINE]Related articlesFree article

Non-HDL cholesterol and apoB in dyslipidaemia.

Sniderman AD, Hogue JC, Bergeron J, Gagné C, Couture P.

Clin Sci (Lond). 2008 Jan;114(2):149-55.PMID: 17868037 [PubMed - indexed for MEDLINE]Related articles

Hypertrophy and hyperplasia of abdominal adipose tissues in women.

Drolet R, Richard C, Sniderman AD, Mailloux J, Fortier M, Huot C, Rhéaume C, Tchernof A.

Int J Obes (Lond). 2008 Feb;32(2):283-91. Epub 2007 Aug 28.PMID: 17726433 [PubMed - indexed for MEDLINE]Related articles

Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease.

Sniderman AD, Holme I, Aastveit A, Furberg C, Walldius G, Jungner I.

Am J Cardiol. 2007 Jul 15;100(2):217-21. Epub 2007 May 30.PMID: 17631073 [PubMed - indexed for MEDLINE]Related articles

Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis.

Sniderman AD, Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A.

Int J Epidemiol. 2007 Feb;36(1):220-5. Review.PMID: 17510078 [PubMed - indexed for MEDLINE]Related articlesFree article

Apolipoprotein A1 and B.

Sniderman AD, Marcovina SM.

Clin Lab Med. 2006 Dec;26(4):733-50. Review.PMID: 17110237 [PubMed - indexed for MEDLINE]Related articles

Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.

ter Avest E, Sniderman AD, Bredie SJ, Wiegman A, Stalenhoef AF, de Graaf J.

Clin Sci (Lond). 2007 Jan;112(2):131-9.PMID: 17054424 [PubMed - indexed for MEDLINE]Related articles

Differential impact of plasma triglycerides on HDL-cholesterol and HDL-apo A-I in a large cohort.

Tremblay AJ, Sniderman AD, Gagné C, Bergeron J, Couture P.

Clin Biochem. 2007 Jan;40(1-2):25-9. Epub 2006 Sep 14.PMID: 17046732 [PubMed - indexed for MEDLINE]Related articles

Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes.

Toledo FG, Sniderman AD, Kelley DE.

Diabetes Care. 2006 Aug;29(8):1845-50.PMID: 16873790 [PubMed - indexed for MEDLINE]Related articlesFree article

Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.

Sniderman AD, Jungner I, Holme I, Aastveit A, Walldius G.

J Intern Med. 2006 May;259(5):455-61. Erratum in: J Intern Med. 2006 Aug;260(2):186. Junger, I [corrected to Jungner, I]. PMID: 16629851 [PubMed - indexed for MEDLINE]Related articles

Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia.

Marcil M, Vu H, Cui W, Dastani Z, Engert JC, Gaudet D, Castro-Cabezas M, Sniderman AD, Genest J Jr, Cianflone K.

Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1619-25. Epub 2006 Apr 20.PMID: 16627811 [PubMed - indexed for MEDLINE]Related articlesFree article

Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?

Jungner I, Sniderman AD, Furberg C, Aastveit AH, Holme I, Walldius G.

Am J Cardiol. 2006 Apr 1;97(7):943-6. Epub 2006 Feb 13.PMID: 16563891 [PubMed - indexed for MEDLINE]Related articles

The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers.

van Oostrom AJ, Alipour A, Plokker TW, Sniderman AD, Cabezas MC.

Atherosclerosis. 2007 Jan;190(1):167-73. Epub 2006 Feb 20.PMID: 16488421 [PubMed - indexed for MEDLINE]Related articles

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, Furberg CD, Gagne C, Haffner SM, Humphries SE, Jungner I, Krauss RM, Kwiterovich P, Marcovina S, Packard CJ, Pearson TA, Reddy KS, Rosenson R, Sarrafzadegan N, Sniderman AD, Stalenhoef AF, Stein E, Talmud PJ, Tonkin AM, Walldius G, Williams KM.

J Intern Med. 2006 Mar;259(3):247-58.PMID: 16476102 [PubMed - indexed for MEDLINE]Related articles

Risk factors for cardiovascular disease in women.

Sniderman AD.

JAMA. 2005 Dec 14;294(22):2843-4; author reply 2844. No abstract available. PMID: 16352785 [PubMed - indexed for MEDLINE]Related articles

Apolipoprotein B versus non-high-density lipoprotein cholesterol: and the winner is...

Sniderman AD.

Circulation. 2005 Nov 29;112(22):3366-7. No abstract available. PMID: 16316960 [PubMed - indexed for MEDLINE]Related articlesFree article

If apoB is so good, why isn't everybody measuring it? One reason why we need The Netherlands Journal of Medicine!

Sniderman AD, Rosenbloom M.

Neth J Med. 2005 Jun;63(6):232-5. No abstract available. PMID: 16011018 [PubMed - indexed for MEDLINE]Related articlesFree article

What do we (not) know about apoB, type 2 diabetes and obesity?

Smith J, Amri MA, Sniderman AD.

Diabetes Res Clin Pract. 2005 Jul;69(1):99-101. No abstract available. PMID: 15955392 [PubMed - indexed for MEDLINE]Related articles

The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.

Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD.

Clin Chem Lab Med. 2004;42(12):1355-63.PMID: 15576296 [PubMed - indexed for MEDLINE]Related articles

Is there value in liver function test and creatine phosphokinase monitoring with statin use?

Sniderman AD.

Am J Cardiol. 2004 Nov 4;94(9A):30F-34F. Review.PMID: 15519289 [PubMed - indexed for MEDLINE]Related articles

Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.

Sattar N, Williams K, Sniderman AD, D'Agostino R Jr, Haffner SM.

Circulation. 2004 Oct 26;110(17):2687-93. Epub 2004 Oct 18.PMID: 15492304 [PubMed - indexed for MEDLINE]Related articlesFree article

Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm.

Sniderman AD.

Curr Opin Lipidol. 2004 Aug;15(4):433-8. Review.PMID: 15243216 [PubMed - indexed for MEDLINE]Related articles

Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3.

van Oostrom AJ, van Dijk H, Verseyden C, Sniderman AD, Cianflone K, Rabelink TJ, Castro Cabezas M.

Am J Clin Nutr. 2004 Mar;79(3):510-5.PMID: 14985229 [PubMed - indexed for MEDLINE]Related articlesFree article

ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes.

Faraj M, Sniderman AD, Cianflone K.

J Lipid Res. 2004 Apr;45(4):657-66. Epub 2004 Jan 1.PMID: 14703506 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).

Williams K, Sniderman AD, Sattar N, D'Agostino R Jr, Wagenknecht LE, Haffner SM.

Circulation. 2003 Nov 11;108(19):2312-6. Epub 2003 Oct 27.PMID: 14581403 [PubMed - indexed for MEDLINE]Related articlesFree article

Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula.

Sniderman AD, Blank D, Zakarian R, Bergeron J, Frohlich J.

Clin Biochem. 2003 Oct;36(7):499-504. Review. No abstract available. PMID: 14563441 [PubMed - indexed for MEDLINE]Related articles

Non-HDL cholesterol versus apolipoprotein B in diabetic dyslipoproteinemia: alternatives and surrogates versus the real thing.

Sniderman AD.

Diabetes Care. 2003 Jul;26(7):2207-8. No abstract available. PMID: 12832337 [PubMed - indexed for MEDLINE]Related articlesFree article

Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk.

Sniderman AD, St-Pierre AC, Cantin B, Dagenais GR, Després JP, Lamarche B.

Am J Cardiol. 2003 May 15;91(10):1173-7.PMID: 12745098 [PubMed - indexed for MEDLINE]Related articles

Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects.

Faraj M, Havel PJ, Phélis S, Blank D, Sniderman AD, Cianflone K.

J Clin Endocrinol Metab. 2003 Apr;88(4):1594-602.PMID: 12679444 [PubMed - indexed for MEDLINE]Related articlesFree article

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, Walldius G.

Lancet. 2003 Mar 1;361(9359):777-80. No abstract available. PMID: 12620753 [PubMed - indexed for MEDLINE]Related articles

Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells.

Sniderman AD, Zhang Z, Genest J, Cianflone K.

J Lipid Res. 2003 Mar;44(3):527-32. Epub 2002 Dec 16.PMID: 12562860 [PubMed - indexed for MEDLINE]Related articlesFree article

The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein.

Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K, Monk PN.

J Biol Chem. 2003 Mar 28;278(13):11123-9. Epub 2003 Jan 22. Erratum in: J Biol Chem. 2004 Jan 2;279(1):820. PMID: 12540846 [PubMed - indexed for MEDLINE]Related articlesFree article

Through a glass darkly: complex modulation of common metabolic faults.

Sniderman AD.

Nutr Metab Cardiovasc Dis. 2002 Aug;12(4):161-2. No abstract available. PMID: 12514934 [PubMed - indexed for MEDLINE]Related articles

How, when, and why to use apolipoprotein B in clinical practice.

Sniderman AD.

Am J Cardiol. 2002 Oct 17;90(8A):48i-54i. Review.PMID: 12419480 [PubMed - indexed for MEDLINE]Related articles

Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice.

Xia Z, Sniderman AD, Cianflone K.

J Biol Chem. 2002 Nov 29;277(48):45874-9. Epub 2002 Sep 19.PMID: 12244109 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipoprotein(a) and atherogenesis: a puzzle inside a riddle within an enigma.

Sniderman AD.

Clin Invest Med. 2002 Jun;25(3):89-91. No abstract available. PMID: 12137257 [PubMed - indexed for MEDLINE]Related articles

A proposal to redefine familial combined hyperlipidaemia -- third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation.

Sniderman AD, Castro Cabezas M, Ribalta J, Carmena R, de Bruin TW, de Graaf J, Erkelens DW, Humphries SE, Masana L, Real JT, Talmud PJ, Taskinen MR.

Eur J Clin Invest. 2002 Feb;32(2):71-3. No abstract available. PMID: 11895451 [PubMed - indexed for MEDLINE]Related articles

Hypertriglyceridemic hyperapoB in type 2 diabetes.

Sniderman AD, Lamarche B, Tilley J, Seccombe D, Frohlich J.

Diabetes Care. 2002 Mar;25(3):579-82.PMID: 11874951 [PubMed - indexed for MEDLINE]Related articlesFree article

How should FCHL be defined and how should we think about its metabolic bases?

Sniderman AD, Ribalta J, Castro Cabezas M.

Nutr Metab Cardiovasc Dis. 2001 Aug;11(4):259-73. Review. No abstract available. Erratum in: Nutr Metab Cardiovasc Dis 2001 Dec;11(6):412. PMID: 11831111 [PubMed - indexed for MEDLINE]Related articles